Welcome to our dedicated page for Cannabis Sativa news (Ticker: CBDS), a resource for investors and traders seeking the latest updates and insights on Cannabis Sativa stock.
Overview of Cannabis Sativa Inc. (CBDS)
Cannabis Sativa Inc. (OTCQB: CBDS) is a diversified company that operates at the intersection of the cannabis and blockchain industries. Through its subsidiaries, including PrestoDoctor, Wild Earth Naturals, White Rabbit, and Hi Brands International, the company develops, manufactures, and markets a wide range of herbal-based skincare products, cannabis formulations, and telemedicine services. CBDS also engages in the research, development, and licensing of cannabis-based products, including edibles, topicals, and delivery systems. By combining its expertise in natural wellness with innovative blockchain solutions, CBDS aims to create value across multiple market segments.
Core Business Areas
- Telemedicine Services: Through PrestoDoctor, CBDS provides online medical cannabis consultations, offering patients a convenient and secure way to access medical marijuana recommendations.
- Herbal-Based Skincare Products: The company offers a range of skincare solutions, including pain relief salves, moisturizing creams, and antioxidant-rich lotions, designed to promote wellness and natural healing.
- Cannabis Product Development: CBDS is actively involved in the research and licensing of cannabis formulations, strains, and delivery systems, leveraging its patented cannabis strain and lozenge for hypertension treatment.
- Blockchain and Digital Assets: Recognizing the transformative potential of blockchain technology, CBDS is expanding into decentralized finance (DeFi) and digital asset markets. The company is exploring tokenization, smart contracts, and blockchain-powered solutions to enhance transparency and efficiency in cannabis supply chains.
Market Position and Competitive Advantages
Operating within the rapidly growing cannabis and blockchain industries, CBDS faces competition from both traditional cannabis companies and emerging blockchain innovators. However, its unique combination of patented cannabis products, telemedicine services, and blockchain initiatives sets it apart. The company's focus on regulatory compliance and innovation further strengthens its market position. By integrating blockchain technology, CBDS aims to address key challenges in the cannabis industry, such as supply chain transparency and financial transaction security.
Strategic Growth Initiatives
- Acquisitions and Partnerships: CBDS actively seeks strategic mergers, acquisitions, and partnerships to expand its influence in both the cannabis and blockchain sectors.
- Digital Asset Strategy: The company is building a robust digital asset portfolio, including its holdings of DogeCoin Cash ($DOG) tokens, to capitalize on the growing DeFi ecosystem.
- Market Expansion: CBDS aims to broaden its market presence by diversifying revenue streams and enhancing shareholder value through innovative solutions.
Future Potential
As the cannabis and blockchain markets continue to evolve, CBDS is well-positioned to capitalize on emerging opportunities. Its focus on integrating blockchain technology into real-world applications, such as cannabis traceability and DeFi solutions, underscores its commitment to innovation. By bridging the gap between natural wellness and decentralized finance, CBDS aims to establish itself as a leader in both industries.
Conclusion
Cannabis Sativa Inc. (CBDS) represents a unique blend of traditional cannabis expertise and forward-thinking blockchain innovation. With its diversified business model, patented products, and strategic focus on emerging technologies, the company is poised to navigate the challenges and opportunities of its dynamic industries.
Cannabis Sativa (OTCQB:CBDS) announced that its Brand Ambassador, Randy Lanier, is featured in Netflix's "Need for Weed", part of the "Bad Sport" docuseries. The episode highlights Lanier's dual career as a race car driver and cannabis importer, detailing his achievements, including the 1984 IMSA Championship and Rookie of the Year at the 1986 Indianapolis 500. Lanier now supports cannabis prisoners via Freedom Grow. CEO David Tobias emphasizes the public’s growing acceptance of cannabis legalization, stating that the docuseries tells a critical story in cannabis history.
Cannabis Sativa, Inc. (OTCQB:CBDS) announced that PrestoDoctor will be a Diamond Sponsor at the Pennsylvania Cannabis Fall Marketplace on October 2 & 3. The event will be held at Renninger's Farmers Market in Kutztown, featuring free admission and over 50 vendors. PrestoDoctor will provide on-site medical evaluations, utilizing their proprietary technology for efficient sign-ups. As a top-rated online cannabis recommendation service, PrestoDoctor has earned over 17,000 five-star reviews and has helped thousands of patients obtain medical cannabis cards across several states.
Cannabis Sativa (OTCQB:CBDS) has launched Cannabis Sativa Magazine, a new digital news platform focusing on cannabis and hemp industry insights. The magazine aims to cover a variety of topics including investor news, politics, lifestyle, and health. CEO David Tobias emphasized that this new domain enhances their intellectual property portfolio. The company continues to explore direct cannabis involvement through innovations in a patented cannabis strain and aims for vertical integration in the industry to improve control over supply chains and product quality.
Cannabis Sativa, Inc. (OTCQB:CBDS) has signed a Term Sheet to acquire Stratum Brands, a cannabis product manufacturer based in Los Angeles, with a 2020 revenue of $2.8 million. Stratum offers various product lines, including Cobra Extracts and LA Kingpins vapes, distributed across over 50 California dispensaries. The acquisition will involve issuing stock valued at $1.715 million for 49% ownership, with an option for further investment post-audit. This strategic move aims to enhance Cannabis Sativa's manufacturing and distribution capabilities.
Cannabis Sativa, Inc. (OTCQB:CBDS) reported Q1 2021 revenues of $557,323, with its subsidiary PrestoDoctor contributing $482,350 and achieving a margin of 62%. This represents a 13% growth compared to Q1 2020. Management anticipates further growth driven by PrestoDoctor’s expansion into newly legalized states for medical marijuana and effective advertising campaigns in Oklahoma and Iowa. The company aims to enhance its presence in the cannabis market through vertical integration, including cultivating its unique cannabis strain and acquiring dispensaries.
Cannabis Sativa, Inc. (OTCQB:CBDS) reported a 75% increase in revenue for the fiscal year ending December 31, 2020, reaching $2,035,383, compared to $1,159,737 in 2019. This growth is attributed to its 51% owned subsidiary PrestoCorp, which benefited from the surge in telemedicine demand due to COVID-19. However, its other subsidiary, GK Manufacturing and Packaging, reported lower revenues of $94,552 and a cost of revenues of $152,837. The company has invested $750,000 in GKMP, which is facing delays in operations.
Cannabis Sativa, Inc. (OTCQB:CBDS) announced that PrestoDoctor will conduct on-site medical evaluations at the Pennsylvania Cannabis Festival on April 17-18. This festival, featuring free admission, leads up to the popular cannabis celebration on 4/20. PrestoDoctor, known for its telemedicine services, has completed over 100 in-person events. The service allows attendees to quickly complete their medical evaluations without traditional clinic visits. PrestoDoctor has received over 15,000 five-star reviews, indicating strong customer satisfaction.
Cannabis Sativa, Inc. (CBDS) announced that its telemedicine service, PrestoDoctor, will host an online event titled Missouri Dispensary 101 on March 13, 2021. The event aims to educate attendees about the Missouri medical cannabis program, available dispensaries, and the process for acquiring medical cannabis cards. Participants will receive a discount code post-event. PrestoDoctor is known for its patient-rated services and has assisted thousands in obtaining medical cannabis cards across several states, including Missouri.
Cannabis Sativa, Inc. (OTCQB:CBDS) announces the expansion of PrestoDoctor, a leading telemedicine service for medical cannabis, into Iowa. Established in 2015, PrestoDoctor has served over 100,000 patients across seven states. CEO David Tobias highlighted that Iowa marks a new market expected to yield significant revenue growth, driven by increasing medical cannabis demand. PrestoDoctor is HIPAA compliant and offers personalized treatment plans, building on its reputation as the top-rated online medical marijuana doctor service with nearly 15,000 five-star reviews.
Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor's Rob Tankson is featured in Forbes Next 1000 Upstart Entrepreneurs, highlighting innovative business leaders. PrestoDoctor, acquired by Cannabis Sativa in 2017 for $9 million, connects 185,000 patients with licensed physicians for medical cannabis recommendations. The telemedicine platform serves multiple states and aims for expansion. With secure video technology, PrestoDoctor ensures patient confidentiality and convenience. It holds a high satisfaction rating with over 14,850 5-star reviews.
FAQ
What is the current stock price of Cannabis Sativa (CBDS)?
What is the market cap of Cannabis Sativa (CBDS)?
What does Cannabis Sativa Inc. (CBDS) do?
How does CBDS generate revenue?
What are CBDS's key competitive advantages?
How is CBDS involved in blockchain technology?
What products does CBDS offer?
What industries does CBDS operate in?
What is PrestoDoctor?
How does CBDS use blockchain in the cannabis industry?
What is DogeCoin Cash ($DOG) in relation to CBDS?
What is the long-term vision of CBDS?
